glp-1 agonist comparison chart Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • Tirzepatide (Manjaro): This is a dual targeting (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic PDB-101: Molecule of the Month:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17














.webp)












